http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1145336-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_12cedce8d26d81271038993ba4912fe6
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J17-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-58
filingDate 1966-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1969-03-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1145336-A
titleOfInvention 17-‡-[3' furyl]-estrogens and process for the preparation thereof
abstract 1,145,336. 17α - Furyl - strogens. AYERST, McKENNA & HARRISON Ltd. 8 June, 1966 [14 Sept., 1965], No. 25574/66. Heading C2U. The invention comprises compounds of formula wherein R is a hydrogen atom or a C 2-4 -aliphatic acyl group and R<SP>1</SP> is a hydrogen atom or a C 1-4 alkyl, C 5-6 cycloalkyl, 2-tetrahydropyranyl or acyl group or a group -SO 3 <SP>-</SP>X<SP>+</SP>, wherein X is a sodium, potassium, calcium, magnesium, barium, ammonium or organic base cation, the dotted lines indicating one optional 7(8) double bond or two optional 6(7) and 8(9) double bonds, and their preparation by reaction of 3-furyllithium with a compound of formula wherein R<SP>1</SP> is a hydrogen atom or a C 1-4 alkyl, C 5-6 cycloalkyl or 2-tetrahydropyranyl group, followed, if desired, by (a) 3 and/or 17-etherification or esterification or (b) reaction of a 3-ol with chlorosulphonic acid in the presence of an organic base, with optional conversion to an ammonium or inorganic salt. 3-(C 2-4 alkyl and C 5-6 cycloalkyl) ethers of equilin and equilenin are prepared by reaction of a sodium or potassium salt of the steroid with an alkyl or cycloalkyl halide. The compounds of the invention have estrogenic activity and may be used in pharmaceutical compositions in combination with a carrier, for example in forms suitable for oral or parenteral administration.
priorityDate 1965-09-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454417423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24638
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419578007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559564
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559505
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444865
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488879
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223368
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559552
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID223
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5460341
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484872
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5355457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5462224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11007813
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559508
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521000

Total number of triples: 35.